Dr. Yongxian Hu

✓ Available through China Expert Care

Chief Physician
Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine

Dr. Yongxian Hu

Focus: CAR-T cell therapy and allogeneic stem cell transplantation for blood cancers

Dr. Hu works at the Bone Marrow Transplantation Center of the First Affiliated Hospital of Zhejiang University School of Medicine. First author of a New England Journal of Medicine study of sequential CD7 CAR-T therapy and allogeneic stem cell transplantation without graft-versus-host disease prophylaxis (2024), and of a study of CRISPR-engineered universal CD19/CD22 CAR-T cells for B-cell acute lymphoblastic leukaemia.

Conditions: CAR-T cell therapy

Selected publications

Profile on the hospital website: https://www.zy91.com/department/doctor/74/451

Request a written opinion from Dr. Yongxian Hu

Send your records. A medical coordinator will reply within 24 hours.

Start here